Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1 - 1,000 - Monthly Reach
Unique listeners across all episodes (30 days)
1 - 5,000 - Active Followers
Loyal subscribers who consistently listen
1 - 500
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Refreshing Key Concepts in Type 2 Diabetes
Aug 22, 2021
Unknown duration
What's New in the 2020 RACGP Guidelines: Special Populations
Aug 22, 2021
Unknown duration
An Update on Microvascular Complications
Aug 22, 2021
Unknown duration
An Update on Diabetes and CVD
Aug 22, 2021
Unknown duration
Mastering the Management of Type 2 Diabetes: Part 1
Aug 22, 2021
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 8/22/21 |  Refreshing Key Concepts in Type 2 Diabetes | Contributors to the RACGP guidelines, Dr Gary Deed (GP) and Michelle Robins (credentialled diabetes educator and nurse practitioner) along with endocrinologist Dr Tom Dover summarise why the updated guidelines were needed. Together, they consider the goals of therapy, what is meant by 'patient-centred care' and how it can be applied in routine clinical practice. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. | — | |
| 8/22/21 |  What's New in the 2020 RACGP Guidelines: Special Populations | Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) discuss the key recommendations relating to some specific patient populations with type 2 diabetes, including early-onset type 2 diabetes, mental health, and the management of type 2 diabetes in older people and in aged-care facilities. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. | — | |
| 8/22/21 |  An Update on Microvascular Complications | Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) discuss microvascular complications including all forms of diabetic-related retinopathy, nephropathy and share their perspectives on medications, diabetic foot risk stratification, examination, and referrals. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. | — | |
| 8/22/21 |  An Update on Diabetes and CVD | Cardiovascular disease (CVD) is the leading cause of death in people with diabetes, making assessment, prevention and management of CVD risk a vital part of diabetes care.1 Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) consider the different risk assessment tools available, interventions to manage CVD risk and practical tips on approaching the multi-morbidity nature of type 2 diabetes and the application of patient-centred care. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. 2. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J. and Broedl, U.C., 2015. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), pp.2117-2128. | — | |
| 8/22/21 |  Mastering the Management of Type 2 Diabetes: Part 1 | Dr Gary Deed (GP) and Dr Tom Dover (endocrinologist) discuss the Australian type 2 diabetes management algorithm developed by the Australian Diabetes Society (ADS), dietary interventions such as high-protein and very low energy diets and pharmacotherapy considerations. Michelle Robins (CDE and nurse practitioner) highlights key educational points for people commencing on certain glucose-lowering agents. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. 2. Martínez-González, M.A., Salas-Salvadó, J., Estruch, R., Corella, D., Fitó, M., Ros, E. and Predimed Investigators, 2015. Benefits of the Mediterranean diet: insights from the PREDIMED study. Progress in cardiovascular diseases, 58(1), pp.50-60. | — | |
| 8/22/21 |  Mastering the Management of Type 2 Diabetes: Part 2 | A continuation of the previous episode, Dr Gary Deed (GP) and Dr Tom Dover (endocrinologist) continue to review the ADS type 2 diabetes treatment algorithm, with an in-depth discussion pharmacotherapy from initial therapies to considerations when selecting second-line agents and when to consider commencing insulin. Michelle Robins shares her tips and considerations on how to overcome inertia to starting insulin. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. | — |
Showing 6 of 6
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.